These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1737024)

  • 21. Purification and characterization of plasma protein C inhibitor.
    España F; Berrettini M; Griffin JH
    Thromb Res; 1989 Aug; 55(3):369-84. PubMed ID: 2551064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress curve analysis of the kinetics with which blood coagulation factor XIa is inhibited by protease nexin-2.
    Scandura JM; Zhang Y; Van Nostrand WE; Walsh PN
    Biochemistry; 1997 Jan; 36(2):412-20. PubMed ID: 9003194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.
    Ogawa T; Verhamme IM; Sun MF; Bock PE; Gailani D
    J Biol Chem; 2005 Jun; 280(25):23523-30. PubMed ID: 15829482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High level expression, purification, and characterization of the Kunitz-type protease inhibitor domain of protease nexin-2/amyloid beta-protein precursor.
    Wagner SL; Siegel RS; Vedvick TS; Raschke WC; Van Nostrand WE
    Biochem Biophys Res Commun; 1992 Jul; 186(2):1138-45. PubMed ID: 1497647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation.
    Baird TR; Walsh PN
    J Biol Chem; 2002 Oct; 277(41):38462-7. PubMed ID: 12167623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of platelets in regulating activated coagulation factor XI activity.
    Reitsma SE; Pang J; Raghunathan V; Shatzel JJ; Lorentz CU; Tucker EI; Gruber A; Gailani D; McCarty OJT; Puy C
    Am J Physiol Cell Physiol; 2021 Mar; 320(3):C365-C374. PubMed ID: 33471623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
    Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
    Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity.
    Rezaie AR; Sun MF; Gailani D
    Biochemistry; 2006 Aug; 45(31):9427-33. PubMed ID: 16878977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis.
    Wu W; Li H; Navaneetham D; Reichenbach ZW; Tuma RF; Walsh PN
    Blood; 2012 Jul; 120(3):671-7. PubMed ID: 22674803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of platelets in the activation of human blood coagulation factor IX by factor XIa.
    Soons H; Janssen-Claessen T; Hemker HC; Tans G
    Blood; 1986 Jul; 68(1):140-8. PubMed ID: 3487352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor.
    Knauer DJ; Majumdar D; Fong PC; Knauer MF
    J Biol Chem; 2000 Dec; 275(48):37340-6. PubMed ID: 10973954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.
    Schmaier AH; Dahl LD; Rozemuller AJ; Roos RA; Wagner SL; Chung R; Van Nostrand WE
    J Clin Invest; 1993 Nov; 92(5):2540-5. PubMed ID: 8227367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bovine plasma protein C inhibitor with structural and functional homologous properties to human plasma protein C inhibitor.
    Suzuki K; Kusumoto H; Nishioka J; Komiyama Y
    J Biochem; 1990 Mar; 107(3):381-8. PubMed ID: 2160449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradation of coagulation proteins by an enzyme from Malayan pit viper (Akistrodon rhodostoma) venom.
    Lollar P; Parker CG; Kajenski PJ; Litwiller RD; Fass DN
    Biochemistry; 1987 Dec; 26(24):7627-36. PubMed ID: 3322404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.
    Meijers JC; Kanters DH; Vlooswijk RA; van Erp HE; Hessing M; Bouma BN
    Biochemistry; 1988 Jun; 27(12):4231-7. PubMed ID: 2844223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human blood coagulation factor XIa by C-1 inhibitor.
    Meijers JC; Vlooswijk RA; Bouma BN
    Biochemistry; 1988 Feb; 27(3):959-63. PubMed ID: 3259145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cabbage seed protease inhibitor: a slow, tight-binding inhibitor of trypsin with activity toward thrombin, activated Stuart factor (factor Xa), activated Hageman factor (factor XIIa), and plasmin.
    Carter TH; Everson BA; Ratnoff OD
    Blood; 1990 Jan; 75(1):108-15. PubMed ID: 2136800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P1 and P2' site mutations convert protease nexin-2 from a factor XIa inhibitor to a plasmin inhibitor.
    Navaneetham D; Wu W; Li H; Sinha D; Tuma RF; Walsh PN
    J Biochem; 2013 Feb; 153(2):221-31. PubMed ID: 23172304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.